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Abstract  
'Impact Factor (IF)' has practically been the only indicator to assess journal 
quality. However, it has a various problems associated with citation analysis, such as the 
effects of "different sizes of audience" and "biased citation". To overcome this dilemma, 
we here propose a new objective index, 'Perspective Factor (PF)', which estimates the 
journal quality independent of "citation analysis". The relationship between IF and PF 
of life science journals published in 1997, for example, gives a positive correlation 
when we excluded review journals and extremely high IF journals such as 'New Engl J 
Med', 'Cell', 'Nature' and 'Science', which could not gain comparatively high PF values. 
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1. Introduction 
In modern society, individual research quality needs to be evaluated in terms of 
its scientific significance as well as its social benefits, including the resultant patents 
and social welfare. The quality of individual scientific research is usually believed to be 
represented by the rank of the journal that publishes the individual research results 
(Taubes, 1993; Vinkler, 1986). Therefore, objective evaluation of journal quality is 
important for such ranking.  
 'Impact Factor' (IF) based on so-called 'citation analysis' (Wade, 1975) has been 
the most well-known and indeed the only indicator to evaluate the journal quality 
(Brody, 1995; Cole and Cole, 1972; Garfield, 1955; Garfield, 1970; Garfield, 1972), 
however, there are concerns about the accuracy of reference citation, and suspicions of 
the impartiality of the citation analysis.  
The effect of 'Biased Citation by authors' is one such problem (Kostoff, 1998; 
MacRoberts and MacRoberts, 1989; Reedijk, 1998; Seglen, 1997). First, since it is 
physically impossible for anyone to read all of the articles that are related to his/her 
research, one can cite only the articles he/she has read. Second, since the articles 
appearing in high IF journals tend to be favorably cited compared to those in low IF 
journals, even if they address the same issues with the same conclusions, and since the 
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articles and/or journals from developed countries are believed to be more reliable than 
those from developing countries, citations can often be biased (Bordons, et al., 2002). 
Third, sometimes the editors of journals force authors to cite articles from their journals 
(Adam, 2002; Massie, 2002; Whitfield, et al., 2002). Therefore, in such cases, citations 
lack the fairness, and the IF values of journals cannot correctly represent the influence 
of the journals on scientific activities.  
Another problem in citation analysis is the effect of 'the size of the journal 
audience’, as it possibly affects the IF estimation (Kostoff, 1998; MacRoberts and 
MacRoberts, 1989; Seglen, 1997). Articles in famous and mass-circulation journals of 
big disciplines are easier to cite than those in minor journals. The last problem is the 
'review effect', which also influences citation analysis in the sense that secondary 
sources are easy to cite (Hecht, et al., 1998; Kostoff, 1998; MacRoberts and 
MacRoberts, 1989; Seglen, 1997).  
 Here, to overcome the shortcomings of IF and to consider journal quality from 
a different point of view, we propose a new indicator, the Perspective Factor, which 
evaluates the perspective of topics contained in journals independent of "citation 
analysis".  
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2. A novel indicator for journals perspectives 
Almost all progress in science is affected by concepts derived from previous 
research activities. Therefore, it is worth evaluating the perspectives of the research that 
influences the following periods of research activities. PF evaluates the perspectives of 
individual journals, instead of individual research articles, using keywords that are 
selected by PubMed independent of the authors of the papers. These keywords represent 
the concepts and topics of the individual articles published in the journal. Then, to 
quantify the degree of the perspective, it calculates the frequency of appearance of these 
concepts and topics before and after publication.  
Thus, the frequency of appearance of key words before and after publication 
acts as a measure of degree of the perspecitive in terms of 'contributing to making given 
fields more popular'. If a given journal publishes several articles that contain many 
perspective key words, it is regarded as a high-perspective journal. Therefore, the PF 
value of a given journal, PFj, is defined as follows: 
Aj 
Bj 
 
PFj = 
 
 
where Bj is the number of articles published in the journal j, and Aj is the number of 
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topics handled in the journal j which became more popular after the journal j was 
published. Thus, the PF value represents the average perspective of topics per article in 
journal j. 
The MeSH (Medical Subject Headings) (Schulman, 2000; Stuart and Johnston) 
words are the most useful to represents the topics in each article, because (i) there is a 
vocabulary thesaurus for the life sciences organized by the NLM (National Library of 
Medicine), and (ii) PubMed (Schulman, 2000; Stuart and Johnston), which uses them, is 
one of the biggest databases of articles in the life sciences (see Methods). MeSH words 
are not written and attached by the author of each article, but by experts who are hired 
by NCBI. Therefore, PF is never affected by bias of the author, and is free from the 
problems associated with the traditional citation analyses. 
An example is the life science journals published in 1997. Here, the Aj value 
can be obtained by counting the MeSH words filling the condition of X/Y>0.5722 in 
journal j on PubMed, where X is the total number of MeSH words appearing in the 
following two years (1998 and 1999), and Y is the total number of MeSH words 
appearing in the four consecutive years including the previous year (1996) and the 
following three years (1997, 1998 and 1999). 'X/Y>0.5722' indicates the condition that 
the increment of a certain MeSH word appearance is included in the top 5 % of the total 
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increment of all MeSH words appearing in 1997 (see Methods); i.e., if the frequency of 
a certain MeSH word appearance fills the X/Y>0.5722 condition, then the topic 
represented by this MeSH word becomes more popular after 1997.  
One may think that the calculation of PF represents temporal trends in science.  
However, the span of X and Y in the equation of PF can be changed for evaluating long 
term perspectives such as Cumulative IF (Garfield, 1998) based on the numbers of 
citations counted over several years. For a comparison of journal quality, we calculated 
the PF values of 161 journals published in 1997 and examined the relationship between 
the IF and PF values (Table 1, Fig. 1 circle dots).  
 
3. Perspective factor vs. impact factor 
Although citing articles by authors and attaching MeSH words to articles by 
experts are completely independent of each other, there is a linear relationship between 
the IF and PF values with a positive Pearson's correlation coefficient, especially in the 
journals with IF<20(r=0.601, p<0.001). The linear correlation between the IF and PF 
values does not hold, however, in some cases. For instance, Cell, Nat Genet, Nat Med, 
New Engl J Med and Lancet, whose IF values are much larger than other journals, have 
PF values relatively smaller than the others. One should handle 'Nature' and 'Science' 
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specifically because they are interdisciplinary scientific journals. Their IF and PF values 
are lower because of limited topics, mainly physics and chemistry, which appear in 
PubMed. Consequently, when handling 'Nature' and 'Science', we selected only articles 
related to life sciences (see Methods). With this restriction, the PF values of 'Nature' and 
'Science' increased to 1.54 and 1.97 from 1.21 and 1.47, respectively (Table 1, Fig.1 
astral dots). Similarly, with this restriction, the IF values of 'Nature' and 'Science' also 
became larger. Even under this consideration, the PF values of certain journals were 
relatively low when the corresponding IF values were very high, i.e., the journals with 
IF values over 20 did not have many topics that had become more popular than 
expected. One major reason for the non-linear relationship between the IF and PF values 
under the condition of IF>20 likely comes from the existence of 'hot papers' (Science 
Watch), 85 % of which are published in 'Nature', 'Cell' and 'Science'. 
When the high-citation articles of 'Nature', 'Cell' and 'Science' were excluded 
from the calculation, the IF values decreased enormously, but the PF values were not 
affected much (Table 1, Fig.1 triangles). Articles dealing the fairness of the IF and 
citation analysis have argued against 'biased citation' (Adam, 2002; Bordons,Fernandez 
and Gomez, 2002; Kostoff, 1998; MacRoberts and MacRoberts, 1989; Massie, 2002; 
Seglen, 1997; Whitfield,Vale and Taylor, 2002), 'citation of secondary sources such as 
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reviews' (Hecht,Hecht and Sandberg, 1998; Kostoff, 1998; MacRoberts and 
MacRoberts, 1989; Seglen, 1997), 'the size of audience in a specific field' (Kostoff, 
1998; MacRoberts and MacRoberts, 1989; Seglen, 1997), and so on. Our analysis 
showed that the review journals had very low PF values compared with their very high 
IF values (Table 1, Fig.1 crosses). In addition, in spite our of expectations, there was no 
correlation between PF values and the size of the research field handled in the journals 
(r = -0.004)(Fig. 2). Finally, the PF value, but not the IF value, can exclude biased 
citation due to the nature of its definition.  
 It may be a worry that highly cited publications trigger the process in which 
professional indexers attach words or terms more favorably to them. If so, the definition 
of PF value itself should allow the high IF journals such as Nature, Cell, New Engl J 
Med to gain high PF values. In reality, however, the PF values for Nature and Cell were 
not so high, and the PF value of New Engl J Med was much lower compared with other 
journals. Therefore the effect of highly cited publications to MeSH words attachment 
shouldbe negligible. 
In conclusion, PF provides a new way of evaluating journal quality as 
'perspective'. When comparing PF and IF values, one can see that the journals can be 
classified into three categories; high IF and low PF journals such as 'Nature', 'Science', 
 9
'Cell' and 'New Engl J Med', low IF and high PF journals such as 'J Comp Biol', 'Mol 
Phylogenet Evol' and 'Mol Biol Rep', and journals which have balanced IF and PF 
values such as 'FEBS Lett', 'J Biol Chem', 'EMBO J' and so on. The concept of 
evaluating perspective is now available for the assessment of research activities through 
journal assessment. Since PF calculation excludes the citation of articles, the resultant 
PF value is not affected by the various problems of citation analysis.   
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Materials and Methods 
Article topics 
PubMed (Schulman, 2000; Stuart and Johnston) has a vocabulary thesaurus, 
namely Medical Subject Headings (MeSH) (Schulman, 2000; Stuart and Johnston), for 
representing the content of each article. MeSH is composed three main classes, ‘MeSH 
Heading’ (Main headings), ‘Subheading ‘(Qualifiers) and ‘Name of Substance’ 
(Supplemental Concepts) and MeSH Heading’ and ‘Name of Substance’ are defined as 
the topics of articles, because ‘Subheading’ is used to qualify ‘MeSH Heading’ and 
indicates how the meaning of ‘MeSH Heading’ should be refined (i.e., how to deal with 
MeSH heading). There is repetition of MeSH words in a single article because of the 
modification of ‘Subheading’ and the duplication of ‘MeSH Heading’ and ‘Name of 
Substance’. Therefore the repetitions were excluded, and one set of MeSH words 
without overlap per article was used to calculate the PF.  
 
Topics becoming much more popular 
To define topics that are increasingly studied, the increase rate of MeSH words 
attached to all articles published in 1997 was examined. There were 434478 articles 
published in 1997 and 5310920 MeSH words (46327 kinds) attached to them. For each 
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MeSH word, we calculated A/B where A is the number of articles published in 1998 and 
1999 containing the MeSH, and B is the number of articles published in 1996, 1997, 
1998 and 1999 containing the MeSH word. The mean value of A/B was 0.513±0.049 
(mean±SD), but the distribution of A/B was not normal (p<0.05). From this result, the 
MeSH words included in the top 5% were defined as being increasingly studied 
(A/B>0.5722).  
 
Life science articles on ‘Nature’ and ‘Science’ and their PF and IF 
‘Nature’ and ‘Science’ contain topics other than life science. Life science 
articles were selected following the ‘Subheading’ attached to the articles; including 
‘Abnormalities’, ‘Adverse Effects’, ‘Agonists’, ‘Anatomy and Histology’, ‘Antagonists’, 
‘Biosynthesis’, ‘Blood’, ‘Blood Supply’, ‘Cerebrospinal Fluid’, ‘Contraindications’, 
‘Cytology’, ‘Deficiency’, ‘Diagnostic’, ‘Dosage’, ‘Embryology’, ‘Enzymology’, 
‘Etiology’, ‘Genetics’, ‘Growth and Development’, ‘Immunology’, ‘Innervation’, 
‘Metabolism’, ‘Microbiology’, ‘Parasitology’, ‘Pathology’, ‘Pharmacokinetics’, 
‘Pharmacology’, ‘Physiology’, ‘Physiopathology’, ‘Poisoning’, ‘Secretion’, ‘Toxicity’, 
‘Transmission’, ‘Ultrastructure’, ‘Urine’ and ‘Virology’. PF was then examined from 
only the life science articles, and the IF was estimated as follows; normal IF times 
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{(sum of the citation number of life science article) by (sum of the total number of life 
science)} by {(sum of the citation number of all articles) by (sum of the total number of 
articles)}. 
 
PF and IF after excluding high-citation articles of ‘Nature’, ‘Science’ and ‘Cell’ 
Using Web of Science, the number of citations of articles of ‘Nature’ (only life 
science articles), ‘Science’ (only life science articles) and ‘Cell’ published in 1997 were 
counted for 2003/03/ (‘Nature’ and ‘Science’) and 2002/03/ (‘Cell’). PF were then 
examined after excluding articles included in the top 5% of citations including Hot 
Papers. IF was estimated as follows; normal IF times {(sum of the citation number after 
excluding the top 5% high-citation life science article) by (sum of the total number 
articles after excluding the top 5% high-citation life science articles)} by {(sum of the 
citation number of all life science articles) by (sum of the total number of all life science 
articles)}. 
 
Field size handled in the journals 
The frequency of appearance of a given MeSH word in a certain year can be 
regarded as the size of a specific field that the MeSH word represents that year. 
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Therefore, the field size handled in a certain journal published in 1997, for example, can 
be defined as the average frequency of the MeSH words’ appearance handled in the 
journal in 1997. Namely, the following equation can be used:  
S = P/Q 
where S is the field size handled in a journal, P is the sum of the frequency of individual 
MeSH words’ appearance on PubMed in a given journal published in 1997, and Q is the 
total number of MeSH words handled in the journal. 
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Figure Caption 
Fig.1 
Correlation between IF and PF; the X axis is the Impact Factor in 1998 and the 
Y axis is the Perspective Factor in 1997. Circles indicate the scores which were 
calculated from all articles in each journal. Astral dots indicate the scores of 'Nature' and 
'Science' which were calculated after articles were restricted to life science, Triangles 
indicate the scores of 'Nature', 'Science' and 'Cell' which were calculated after articles 
were restricted to life science and high-citation articles were excluded, and crosses 
indicate review journals.  
 
Fig.2 
Correlation between PF and the size of research fields; the X axis is the size of 
the research field handled in the journal and the Y axis is the Perspective Factor in 1997. 
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Journal Titlea IFb PFc Journal Titlea IFb PFc Journal Titlea IFb PFc
Cell 38.1 1.93 Virology 3.6 0.93 Plant Cell Physiol 1.8 0.92
New Engl J Med 28.9 0.55 Genomics 3.5 0.90 Mol Immunol 1.8 1.10
Nature 28.8 1.21 J Neurophysiol 3.4 0.56 Genet Res 1.8 0.74
Science 24.4 1.47 Appl Environ Microbiol 3.4 1.12 J Neurovirol 1.7 0.48
Immunity 20.5 2.12 J Neuroimmunol 3.3 0.52 Histopathology 1.7 0.42
Genes Dev 19.1 2.34 J Mol Evol 3.3 1.79 Biotechniques 1.7 0.59
Neuron 16.5 1.19 Eur J Biochem 3.2 1.03 Histochem Cell Biol 1.7 0.55
J Exp Med 15.9 1.59 Dev Dyn 3.2 1.15 Neurochem Res 1.7 0.53
Nat Struct Biol 13.6 1.99 J Membr Biol 3.2 0.96 Dev Psychobiol 1.6 0.35
Embo J 13.2 2.21 Int Immunol 3.1 1.16 Int J Biochem Cell Biol 1.6 0.73
J Cell Biol 12.8 1.83 Mol Ecol 3.0 1.07 Virus Res 1.6 1.07
Mol Cell 12.4 2.50 Plant Mol Biol 3.0 1.16 Int J Dev Biol 1.6 0.75
Faseb J 11.9 1.07 Hum Genet 2.8 0.97 Biophys Chem 1.6 0.64
Plant Cell 11.8 1.82 Methods Enzymol 2.8 0.92 J Virol Methods 1.6 0.48
Am J Hum Genet 10.9 1.31 J Cell Biochem 2.8 1.20 Cell Mol Life Sci 1.5 0.82
Lancet 10.7 0.44 Mol Gen Genet 2.8 0.95 Med Microbiol Immunol 1.5 0.59
Development 9.7 2.27 J Struct Biol 2.8 1.17 Int J Dev Neurosci 1.5 0.35
Mol Cell Biol 9.6 2.04 Immunology 2.8 1.00 Mol Biol Rep 1.5 1.85
Hum Mol Genet 9.3 1.32 J Cell Physiol 2.7 1.01 Anat Embryol 1.5 0.52
J Neurosci 8.4 0.95 J Gen Virol 2.7 0.86 Cell Struct Funct 1.5 1.03
Mol Biol Cell 8.3 1.84 Chromosoma 2.7 0.89 J Biotechnol 1.5 0.74
Cereb Cortex 7.4 0.25 J Med Genet 2.6 0.70 Histol Histopathol 1.4 0.42
J Biol Chem 7.1 1.52 J Med Virol 2.6 0.72 Immunol Lett 1.4 0.96
J Gen Physiol 6.3 0.47 J Immunother 2.6 0.48 Histochem J 1.4 0.62
Oncogene 6.2 1.88 J Pineal Res 2.5 0.30 Immunobiology 1.4 1.37
Chem Biol 6.2 1.26 J Histochem Cytochem 2.5 0.64 J Comput Biol 1.3 2.08
Mol Microbiol 6.1 0.97 Dev Genet 2.5 1.32 Clin Biochem 1.3 0.54
Brain Res Dev Brain Res 6.0 0.38 Eur J Cell Biol 2.5 0.98 J Protein Chem 1.3 0.72
J Mol Biol 5.8 1.51 Placenta 2.5 0.46 Mol Cell Biochem 1.3 0.62
Plant J 5.8 1.77 Mol Reprod Dev 2.4 0.75 Res Microbiol 1.3 0.85
Hum Gene Ther 5.6 0.69 Immunogenetics 2.3 0.80 Immunopharmacology 1.2 0.63
J Cell Sci 5.5 1.30 J Autoimmun 2.3 0.72 Biol Cell 1.1 0.71
Eur J Immunol 5.4 1.39 Chromosome Res 2.3 0.75 J Appl Microbiol 1.1 0.65
Mol Pharmacol 5.4 1.00 Yeast 2.2 0.84 Rissue Cell 1.0 0.66
Gene Ther 5.4 0.61 J Biochem 2.2 1.00 Mol Biotechnol 1.0 0.34
Mol Biol Evol 5.3 2.23 Hum Immunol 2.2 0.54 Somat Cell Mol Genet 0.9 1.14
Nucleic Acid Res 4.9 0.94 Dna Cell Biol 2.2 1.02 J Mol Recognit 0.9 1.48
Mol Med 4.9 1.15 J Neurocytol 2.2 0.60 Cell Biol Int 0.9 0.56
Mech Dev 4.9 2.01 Brain 2.2 0.53 Biochem Genet 0.9 0.44
J Physiol 4.7 0.52 Eur J Hum Genet 2.2 1.12 Pathobiology 0.8 1.08
J Neurochem 4.7 0.99 Cell Immunol 2.1 1.06 J Biochem Biophys Methods 0.8 0.40
Biochemistry 4.6 1.16 Differentiation 2.1 0.85 Gen Physiol Biophys 0.7 0.25
Plant Physiol 4.5 1.19 Cell Tissue Res 2.1 0.54 Appl Biochem Biotechnol 0.7 0.75
Genetics 4.5 1.31 Ultramicroscopy 2.0 1.00 Res Commun Mol Pathol Pharmacol 0.6 0.56
Genes Cells 4.3 1.33 Am J Med Genet 2.0 0.47 Cell Biochem Funct 0.5 0.53
Cell Growth Differ 4.3 1.97 Gene 2.0 1.03 J Immunoassay 0.5 0.57
J Leukoc Biol 4.3 1.01 Anal Biochem 2.0 0.71 Cell Biol Toxicol 0.5 0.82
Biochem J 3.9 1.15 Biosci Rep 2.0 0.84 Eur J Histochem 0.5 0.61
Eur J Neurosci 3.8 0.52 Methods Cell Biol 2.0 0.57 Nature(only life science issues) 42.0 1.54
J Bacteriol 3.8 1.00 J Med Microbiol 2.0 0.52 Science(only life science issues) 31.2 1.97
Mol Phylogenet Evol 3.8 2.24 Cell Mol Neurobiol 2.0 0.74 Cell(excluding high citation issues) 29.9 1.84
Br J Pharmacol 3.7 0.74 J Mol Neurosci 1.9 0.73 Nature(excluding high citation issues 31.2 1.45
Neuroscience 3.6 0.74 J Clin Immunol 1.9 0.93 Science(excluding high citation issue 21.8 1.85
Febs Lett 3.6 1.22 Immunol Cell Biol 1.9 0.94
J Clin Microbiol 3.6 0.55 Cytogenet Cell Genet 1.9 0.57
aThe notation system of journals follows to PubMed.
bImpact Factor in 1998
cPerspective Factor in 1997
Table 1  PF and IF of the journals in life science
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